Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Norina Tanaka, MD PhD, Aya Watanabe, MD, Suguru Honda, MD, Mitsuko Kobayashi, Yan-Hua Wang, MD, Yuki Iizuka, MD, Michiko Ryuzaki, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Katsunori Ikari, MD PhD, Masayuki Shiseki, MD PhD, Masayoshi Harigai, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 5219.

https://doi.org/10.1182/blood-2019-127836

Published: 2019

Journal Articles

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Shotaro Hagiwara, MD PhD, Yan-Hua Wang, MD, Hirohito Kobayashi, MD, Yutaka Kato, MD, Norina Tanaka, MD PhD, Yuki Iizuka, MD, Aya Watanabe, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD PhD, Hitoshi Kanno, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 3133.

https://doi.org/10.1182/blood-2019-127739

Published: 2019

Journal Articles

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Yan-Hua Wang, MD PhD, Toshiko Motoji, MD PhD, Yoichi Imai, MD PhD, Masayuki Shiseki, MD PhD, Kenjiro Mitsuhashi, MD, Ye Ding, MD, Junji Tanaka, MD PhD

Blood (2014) 124 (21): 2225.

https://doi.org/10.1182/blood.V124.21.2225.2225

Published: 2014

Journal Articles

Inhibition of PRAME Expression Causes Cell Cycle Arrest and Apoptosis In Leukemic Cells

Norina Tanaka, MD, Yan-Hua Wang, MD, Masayuki Shiseki, MD, Minoko Takanashi, MD, Toshiko Motoji, MD

Blood (2010) 116 (21): 1695.

https://doi.org/10.1182/blood.V116.21.1695.1695

Published: 2010

Journal Articles

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Naoki Mori, MD, PhD, Kentaro Yoshinaga, MD, PhD, Mari Ohwashi, MHS, Toshiaki Kondoh, MD, Hanae Shimura, MD, Yan-Hua Wang, MD, PhD, Kenjiro Mitsuhashi, MD, Masayuki Shiseki, MD, PhD, Michiko Okada, PhD, Toshiko Motoji, MD, PhD

Blood (2010) 116 (21): 5112.

https://doi.org/10.1182/blood.V116.21.5112.5112

Published: 2010

NARROW

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Inhibition of PRAME Expression Causes Cell Cycle Arrest and Apoptosis In Leukemic Cells

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Inhibition of PRAME Expression Causes Cell Cycle Arrest and Apoptosis In Leukemic Cells

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only